Literature DB >> 16781709

Characterization of two distinct liver progenitor cell subpopulations of hematopoietic and hepatic origins.

V Corcelle1, B Stieger, A Gjinovci, C B Wollheim, B R Gauthier.   

Abstract

Despite extensive studies, the hematopoietic versus hepatic origin of liver progenitor oval cells remains controversial. The aim of this study was to determine the origin of such cells after liver injury and to establish an oval cell line. Rat liver injury was induced by subcutaneous insertion of 2-AAF pellets for 7 days with subsequent injection of CCl(4). Livers were removed 9 to 13 days post-CCl(4) treatment. Immunohistochemistry was performed using anti-c-kit, OV6, Thy1, CK19, AFP, vWF and Rab3b. Isolated non-parenchymal cells were grown on mouse embryonic fibroblast, and their gene expression profile was characterized by RT-PCR. We identified a subpopulation of OV6/CK19/Rab3b-expressing cells that was activated in the periportal region of traumatized livers. We also characterized a second subpopulation that expressed the HSCs marker c-kit but not Thy1. Although we successfully isolated both cell types, OV6/CK19/Rab3b(+) cells fail to propagate while c-kit(+)-HSCs appeared to proliferate for up to 7 weeks. Cells formed clusters which expressed c-kit, Thy1 and albumin. Our results indicate that a bona fide oval progenitor cell population resides within the liver and is distinct from c-kit(+)-HSCs. Oval cells require the hepatic niche to proliferate, while cells mobilized from the circulation proliferate and transdifferentiate into hepatocytes without evidence of cell fusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781709     DOI: 10.1016/j.yexcr.2006.05.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes.

Authors:  Tammy T Chang; Millie Hughes-Fulford
Journal:  Tissue Eng Part A       Date:  2009-03       Impact factor: 3.845

2.  Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells.

Authors:  Wei-hui Liu; Ren Li; Ke-feng Dou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 3.  Proteomic research progress in lymphatic metastases of cancers.

Authors:  Junwei Zong; Chunmei Guo; Shuqing Liu; Ming-Zhong Sun; Jianwu Tang
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

4.  Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.

Authors:  Caecilia Hc Sukowati; Natalia Rosso; Lory S Crocè; Claudio Tiribelli
Journal:  World J Hepatol       Date:  2010-03-27

Review 5.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

6.  Propitious role of bone marrow-derived mononuclear cells in an experimental bile duct ligation model: potential clinical implications in obstructive cholangiopathy.

Authors:  Shilpa Sharma; Sujata Mohanty; Prasenjit Das; Sidhartha DattaGupta; Lalit Kumar; Devendra Gupta
Journal:  Pediatr Surg Int       Date:  2013-04-19       Impact factor: 1.827

7.  Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma.

Authors:  Chao-Wei Lee; Sey-En Lin; Hsin-I Tsai; Po-Jung Su; Chia-Hsun Hsieh; Yung-Chia Kuo; Chang-Mu Sung; Cheng-Yu Lin; Chi-Neu Tsai; Ming-Chin Yu
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

8.  The use of cellular technologies in treatment of liver pathologies.

Authors:  O S Petrakova; E S Chernioglo; V V Terskikh; E N Kalistratova; A V Vasiliev
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

9.  The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.

Authors:  Chao-Wei Lee; Wen-Ling Kuo; Ming-Chin Yu; Tse-Ching Chen; Chi-Neu Tsai; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Surg Oncol       Date:  2013-06-12       Impact factor: 2.754

Review 10.  Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies.

Authors:  Hedwig S Kruitwagen; Bart Spee; Baukje A Schotanus
Journal:  BMC Vet Res       Date:  2014-06-19       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.